| Particulars |
|
|
|
| Company Name
| Jagsonpal Pharmaceuticals Ltd
| Year End
| 202603
|
| Full Year |
| Equity (₹ Cr.) |
13.43 |
B.V. (₹) |
41.10 |
| Sales(₹ Cr.) |
287.23 |
NP (₹ Cr.) |
44.64 |
| NP Var (%) |
12.00 |
Div% |
200.00 |
| CPS(₹) |
8.10 |
EPS (₹) |
6.60 |
| Traded Value(₹ Lakhs) |
15.10 |
52 Week High |
302.00 |
| 52 Week Low |
155.00 |
Price BSE |
213.00 |
| P/C Ratio |
26.40 |
P/E Ratio |
32.00 |
| Price Vs.BV |
5.18 |
|
| Latest Quarter |
| Year End |
202603 |
Sales (₹ Cr.) |
64.20 |
| NP(₹ Cr.) |
8.76 |
NP Var % |
30.00 |
| Trailing Twelve Months |
| Year End |
202603 |
Sales |
226.85 |
| OPM |
13.83 |
NP |
26.76 |
| NP Var (%) |
12.43 |
EPS |
6.65 |
| PE |
31.98 |
|
|